Compare Repligen Corporation Common Stock (RGEN) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Clear Secure Inc — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B), while Clear Secure Inc trades at $44.26 (market cap $4.57B). The key difference: Repligen Corporation Common Stock is far larger — about 2.5× Clear Secure Inc's market cap, and Clear Secure Inc pays a 1.3% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Clear Secure Inc for 20 Days on average.
| RGEN | YOU | |
|---|---|---|
Market Cap | $11.31B | $4.57B |
Volume | 1,216,919 | 1,514,917 |
Sector | Health | Technology |
52-Week High | $194.57 | $62.36 |
52-Week Low | $102.87 | $30.47 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $11.20B | $3.72B |
Dividend Yield | — | 1.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Clear Secure (YOU) trades at $43.52, up 2.5% over the past day, with a mixed technical picture showing bearish moving averages but neutral oscillators. Fundamentally, the company reported strong Q2 2026 results with EPS of $0.49 beating estimates, revenue growth of 27% year-over-year, and robust profitability metrics including a 66.66% gross margin. Recent developments include a strategic partnership with CrowdStrike and the launch of corporate memberships.
The outlook is positive given accelerating membership growth and expanding margins, though risks include competitive pressures and reliance on airport services. Analysts are generally bullish with a consensus price target of $61.40, representing significant upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
